SECA recent SEC settlement of whistleblower charges should serve as a useful reminder for private fund sponsors to conduct a comprehensive review of their policies and procedures.

On August 10, 2016, the SEC announced that BlueLinx Holdings Inc., an Atlanta-based building products distributor, had settled charges that it violated securities laws by using severance agreements that contravened Dodd-Frank provisions prohibiting employers from impeding whistleblower reporting.  Specifically, the severance agreements required outgoing employees to waive their rights to monetary recoveries in the event that they filed a charge or complaint with the SEC or other federal agency.  In settlement, BlueLinx agreed to pay $265,000, amend its severance agreements, and inform former employees that they are not prohibited from providing information to the SEC or accepting whistleblower awards.

As the SEC’s Division of Enforcement further develops and relies on its whistleblower program, private fund sponsors should be conducting a comprehensive review to proactively ensure that their policies and procedures are up-to-date and consistent across their organization. This review can demonstrate to both employees and regulatory authorities that the firm takes seriously its responsibilities relating to whistleblowers.

Private fund sponsors frequently have provisions affecting whistleblowers in various agreements, polices and manuals utilized across the enterprise, such as:

  • employee manuals, handbooks and policies,
  • codes of conduct,
  • employment agreements,
  • confidentiality and non-compete agreements,
  • separation agreements,
  • compliance manuals,
  • LLC, partnership and shareholder agreements,
  • procedures for internal investigations, or
  • consulting and licensing agreements.

A key issue for private fund sponsors is ensuring consistency. Policies should encourage a clear and available avenue for internal reporting, while avoiding any language that might impede an employee from making protected disclosures to governmental agencies.  Given the compressed time frame to address potential violations, senior employees must be attentive to concerns raised by subordinates and assure them that their concerns are being taken seriously and investigated thoroughly.

By now, private fund sponsors should have modified any language in confidentiality agreements that could be interpreted as discouraging potential whistleblowers from contacting a government agency, conforming with the guidance contained in the SEC’s April 1, 2015 action against KBR Inc.  Even in the absence of a formal internal investigation, sponsors should be careful using any language that requires a current or former employee to obtain the prior approval of the firm’s legal department before discussing underlying facts with the government.

Where a fund adviser had previously used a broad, pre-KBR confidentiality agreement, should that adviser reach out to former employees to let them know that they remain free to communicate with the government?  It is a judgment call, but certain SEC exam staff might have this expectation.

A private fund sponsor’s review should not be limited to its own employees. Where a sponsor uses operating partners or other service providers in connection with managing a fund’s portfolio companies, the firm should also address whistleblower provisions in agreements with those quasi-independent individuals or entities.  Indeed, according to the SEC’s most recent whistleblower program report (at 16-17), over half of the SEC’s whistleblower awards have gone to non-employees.  As we discussed here, under certain circumstances, a private fund’s auditor or legal and compliance staff might even be an eligible whistleblower.

In addition to the SEC, fund advisers should be aware of other federal and state agencies that may impose additional whistleblower protection requirements. Two key examples:

  • Since passage of the Occupational Safety and Health Act of 1970, Congress has expanded OSHA’s whistleblower authority to protect workers from retaliation under twenty-two federal laws—an important consideration for portfolio companies with government contracts.
  • The Defend Trade Secrets Act (DTSA), which went into effect on May 11, 2016, contains a whistleblower immunity provision. Among other things, the DTSA provides that an individual cannot be held liable for disclosure of a trade secret made in confidence to a government official or to an attorney for the sole purpose of reporting or investigating a suspected legal violation. To comply with the DTSA’s notice requirement, an employer should consider either incorporating the immunity provisions into a contract or agreement or including in the agreement a cross-reference to the employer’s whistleblower policy containing an immunity provision. It is an open question whether a cross-reference to a stand-alone policy will satisfy the Dodd-Frank whistleblower retaliation prohibitions.

Finally, private fund sponsors should integrate whistleblower training into ongoing compliance educational programs for employees. These trainings should emphasize the internal reporting channels available to employees, and the firm should keep comprehensive documentation of the training.

Private fund sponsors should be mindful that there are whistleblower implications across many facets of the sponsor’s enterprise and its relationship with third parties. As discussed previously, and particularly following the BlueLinx enforcement action, all employers (including all private fund sponsors) should promptly review materials that contain confidentiality, non-disclosure, non-disparagement and whistleblower provisions to ensure that they are prepared to proactively respond to a potential whistleblower situation.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Joshua M. Newville Joshua M. Newville

Joshua M. Newville is a partner in the Litigation Department and a member of Proskauer’s White Collar Defense & Investigations Group and the Asset Management Litigation team.

Josh handles securities litigation, enforcement and regulatory matters, representing corporations and senior executives in civil and…

Joshua M. Newville is a partner in the Litigation Department and a member of Proskauer’s White Collar Defense & Investigations Group and the Asset Management Litigation team.

Josh handles securities litigation, enforcement and regulatory matters, representing corporations and senior executives in civil and criminal investigations. In addition, Josh advises registered investment advisers and private fund managers on regulatory compliance, SEC exams, MNPI/insider trading and related risks.

Before joining Proskauer, Josh was senior counsel in the U.S. Securities and Exchange Commission’s Division of Enforcement, where he investigated and prosecuted violations of the federal securities laws. Josh served in the Enforcement Division’s Asset Management Unit, a specialized unit focusing on investment advisers and the asset management industry. His prior experience with the SEC provides a unique perspective to help asset managers manage risk and handle regulatory issues.

Photo of Timothy W. Mungovan Timothy W. Mungovan

Tim Mungovan is the Chair of Proskauer.  He is also the immediate past chair of the Firm’s Litigation Department and head of the Securities Litigation practice.

His practice is focused on securities, commercial litigation, governance, and bankruptcy-related matters. He has a national reputation…

Tim Mungovan is the Chair of Proskauer.  He is also the immediate past chair of the Firm’s Litigation Department and head of the Securities Litigation practice.

His practice is focused on securities, commercial litigation, governance, and bankruptcy-related matters. He has a national reputation for advising sponsors of private investment funds (hedge, private equity, private credit and venture capital) in a wide variety of matters, including litigation, governance, securities, fiduciary obligations, and regulatory enforcement.

Chambers USA describes Tim as “an extraordinary lawyer who is a fierce and very talented litigator. He is extremely knowledgeable, responsive and client-oriented.” Best Lawyers in America lauds Tim’s experience, integrity, work ethic, communications and courtroom skills. Tim has been listed in the “Top 100 Lawyers” in Massachusetts, and Benchmark Litigation has continually recognized Tim as a Litigation Star in Massachusetts.

Over the last six years, Tim has been the lead litigator representing the Financial Oversight and Management Board for Puerto Rico in the historic restructuring of Puerto Rico’s debts. The scale and complexity of this restructuring has resulted in one of the most active litigation dockets in the U.S. Almost every aspect of the litigation involved matters of first impression in part because the restructuring is governed by the Puerto Rico Oversight, Management, and Economic Stability Act, which was enacted for Puerto Rico in 2016.  The track record of success speaks for itself:  in the more than 150 lawsuits filed, Tim and the Proskauer team have prevailed in almost 95% of the cases.

Tim is recognized nationally for his experience in private fund litigation and disputes, having focused on the industry for more than 25 years.  As part of that focus, Tim created and is the lead editor of Proskauer’s blog on Private Equity litigation, The Capital Commitment.

Photo of Michael R. Hackett Michael R. Hackett

Mike Hackett is a partner in the Litigation Department and Co-Head of the Asset Management Litigation practice. An experienced litigator and trial lawyer, Mike’s practice focuses on complex commercial litigation, with a particular emphasis on asset management, financial services, M&A, shareholder, and life…

Mike Hackett is a partner in the Litigation Department and Co-Head of the Asset Management Litigation practice. An experienced litigator and trial lawyer, Mike’s practice focuses on complex commercial litigation, with a particular emphasis on asset management, financial services, M&A, shareholder, and life sciences disputes.

A significant portion of Mike’s practice concerns disputes and regulation involving private funds, including private equity, venture capital, hedge, real estate and private credit funds, as well as their sponsors, partners, investors, portfolio companies, and officers and directors. Mike’s experience representing private fund clients runs the gamut, from control contests within advisers, to disputes between limited partners and general partners, to representation of investment advisers in connection with regulatory examinations, investigations and enforcement matters. Mike routinely represents funds, fund sponsors, portfolio companies, and their officers and directors, including in significant post-closing M&A disputes.

Mike also litigates high-stakes commercial disputes in the life sciences and financial services areas, including for established pharmaceutical and biotechnology companies, emerging and innovative start-ups, asset managers, and other private capital investors, in areas such as M&A, breach of contract, indemnification, fraud, contested earnouts and royalties, securities and capital markets, and corporate governance.

Mike has been recognized by Chambers USA and was named a “Rising Star” by Massachusetts Super Lawyers.